We are live on ! Find out more
ADMA icon

ADMA Biologics
ADMA

72 hedge funds and large institutions have $47.3M invested in ADMA Biologics in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 26 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.86% less ownership

Funds ownership: 33.46% → 32.6% (-0.86%)

20% less funds holding

Funds holding: 90 → 72 (-18)

27% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 26

30% less capital invested

Capital invested by funds: $67.7M → $47.3M (-$20.4M)

75% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 24

78% less call options, than puts

Call options by funds: $473K | Put options by funds: $2.14M

Holders
72
Holders Change
-18
Holders Change %
-20%
% of All Funds
1.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
19
Reduced
26
Closed
24
Calls
$473K
Puts
$2.14M
Net Calls
-$1.67M
Net Calls Change
+$1.11M

Top Buyers

1
BFM
Boothbay Fund Management
New York
+$4.07M
2
N
Nuveen
North Carolina
+$1.37M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$776K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$364K
5
Morgan Stanley
Morgan Stanley
New York
+$305K

Top Sellers

1
PA
Perceptive Advisors
New York
-$4.65M
2
Millennium Management
Millennium Management
New York
-$589K
3
SSA
Schonfeld Strategic Advisors
New York
-$513K
4
E
Ergoteles
New York
-$479K
5
Barclays
Barclays
United Kingdom
-$461K
Name Holding Trade Value Shares
Change 		Change in
Stake
RJFSA
26
Raymond James Financial Services Advisors
Florida
$123K +$47.7K +34,080 +45%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$117K -$50.6K -36,095 -26%
BBP
28
Banco BTG Pactual
Brazil
$105K – – –
Squarepoint
29
Squarepoint
New York
$104K -$283K -201,933 -69%
Deutsche Bank
30
Deutsche Bank
Germany
$97K – – –
Assenagon Asset Management
31
Assenagon Asset Management
Luxembourg
$92K +$26.9K +19,169 +31%
SSA
32
Schonfeld Strategic Advisors
New York
$86K -$513K -365,873 -83%
AAS
33
Avantax Advisory Services
Texas
$81K -$105K -74,710 -51%
TI
34
Telemetry Investments
New York
$68K +$84K +60,000 New
GC
35
Grimes & Company
Massachusetts
$61K – – –
Bank of New York Mellon
36
Bank of New York Mellon
New York
$52K -$18.7K -13,316 -22%
NFSG
37
Newbridge Financial Services Group
Florida
$52K +$64.5K +46,050 New
CS
38
Credit Suisse
Switzerland
$40K +$49K +35,000 New
ECM
39
ExodusPoint Capital Management
New York
$39K +$48.6K +34,697 New
Jane Street
40
Jane Street
New York
$38K -$30.8K -21,971 -40%
HSBC Holdings
41
HSBC Holdings
United Kingdom
$36K -$1.72K -1,225 -4%
HP
42
Hikari Power
Japan
$34K – – –
CG
43
Cutler Group
California
$32K -$25K -17,859 -38%
Commonwealth Equity Services
44
Commonwealth Equity Services
Massachusetts
$28K -$7K -5,000 -17%
SWP
45
Stratos Wealth Partners
Ohio
$23K – – –
Principal Financial Group
46
Principal Financial Group
Iowa
$21K -$4.26K -3,043 -14%
UBS Group
47
UBS Group
Switzerland
$21K +$18.9K +13,460 +271%
XT
48
XTX Topco
Cayman Islands
$20K -$10K -7,172 -29%
EAM
49
Eagle Asset Management
Florida
$20K – – –
VPIM
50
Vanguard Personalized Indexing Management
California
$20K +$24.7K +17,630 New
1
2
3 4

ADMA Hedge Fund Activity: Q3 2021 in Review

72 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in ADMA Biologics (ADMA) for Q3 2021, worth a combined $47.3M — down 30% from $67.7M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of ADMA and 6 opened new positions — a net loss of 18 holders — while 26 trimmed existing stakes and 19 added.

The largest buyer was Boothbay Fund Management, adding an estimated $4.07M. The largest seller was Perceptive Advisors, cutting an estimated $4.65M.

  • 72 institutional investors held ADMA Biologics (ADMA) as of Q3 2021, down from 90 in Q2 2021.
  • Funds reported $47.3M of ADMA Biologics stock for Q3 2021, down 30% quarter-over-quarter.
  • 6 funds opened new ADMA Biologics positions in Q3 2021 and 24 closed out, a net change of -18 holders.
  • The largest ADMA Biologics buyer in Q3 2021 was Boothbay Fund Management, an estimated $4.07M added.
  • The largest ADMA Biologics seller in Q3 2021 was Perceptive Advisors, an estimated $4.65M sold.

Based on aggregated 13F filings for Q3 2021.